Centiva Capital’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$199K Buy
+7,500
New +$199K ﹤0.01% 1030
2024
Q3
Sell
-67,633
Closed -$3.59M 2022
2024
Q2
$3.59M Buy
+67,633
New +$3.59M 0.06% 108
2022
Q4
Sell
-10,840
Closed -$29K 1153
2022
Q3
$29K Buy
+10,840
New +$29K ﹤0.01% 880